Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

The private for-profit sector is an important source of treatment for malaria. However, private patients face high prices for the recommended treatment for uncomplicated malaria, artemisinin combination therapies (ACTs), which makes them more likely to receive cheaper, less effective non-artemisinin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Health Policy Plan
Main Authors: Palafox, Benjamin, Patouillard, Edith, Tougher, Sarah, Goodman, Catherine, Hanson, Kara, Kleinschmidt, Immo, Torres Rueda, Sergio, Kiefer, Sabine, O’Connell, Kate, Zinsou, Cyprien, Phok, Sochea, Akulayi, Louis, Arogundade, Ekundayo, Buyungo, Peter, Mpasela, Felton, Poyer, Stephen, Chavasse, Desmond
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://ncbi.nlm.nih.gov/pubmed/25944705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/heapol/czv031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados